HC Wainwright Increases Earnings Estimates for Adlai Nortye

Adlai Nortye Ltd. Sponsored ADR (NASDAQ:ANL) – Equities research analysts at HC Wainwright raised their FY2026 earnings per share estimates for Adlai Nortye in a research report issued on Friday, August 14th. HC Wainwright analyst J. Pantginis now anticipates that the company will earn ($0.17) per share for the year, up from their prior forecast of ($0.23). HC Wainwright currently has a “Buy” rating and a $20.00 target price on the stock. The consensus estimate for Adlai Nortye’s current full-year earnings is ($0.32) per share. HC Wainwright also issued estimates for Adlai Nortye’s FY2027 earnings at ($0.16) EPS and FY2028 earnings at ($0.19) EPS.

ANL has been the topic of several other research reports. Oppenheimer initiated coverage on shares of Adlai Nortye in a research note on Thursday, May 28th. They set an “outperform” rating and a $32.00 target price on the stock. JonesTrading initiated coverage on shares of Adlai Nortye in a research note on Thursday, May 14th. They issued a “buy” rating and a $22.00 price target for the company. Weiss Ratings reissued a “sell (e+)” rating on shares of Adlai Nortye in a report on Tuesday, July 14th. Finally, Cantor Fitzgerald began coverage on shares of Adlai Nortye in a research report on Monday, June 22nd. They set an “overweight” rating on the stock. Five research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $24.25.

Adlai Nortye Trading Up 0.7%

NASDAQ ANL opened at $13.34 on Tuesday. Adlai Nortye has a one year low of $0.88 and a one year high of $17.25. The stock has a 50-day moving average of $11.50 and a 200 day moving average of $10.88.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the company. SmartHarvest Portfolios LLC boosted its position in Adlai Nortye by 8.5% in the first quarter. SmartHarvest Portfolios LLC now owns 16,367 shares of the company’s stock worth $113,000 after purchasing an additional 1,279 shares during the last quarter. Renaissance Technologies LLC bought a new stake in shares of Adlai Nortye during the 1st quarter valued at about $457,000. ADAR1 Capital Management LLC purchased a new stake in shares of Adlai Nortye during the 1st quarter valued at about $816,000. Affinity Asset Advisors LLC purchased a new stake in shares of Adlai Nortye during the 1st quarter valued at about $1,140,000. Finally, Boone Capital Management LLC bought a new position in shares of Adlai Nortye in the 2nd quarter worth approximately $2,971,000. Institutional investors own 35.21% of the company’s stock.

About Adlai Nortye

Adlai Nortye Inc (NASDAQ: ANL) is a specialty chemical manufacturer headquartered in China’s Jiangsu Province. The company focuses on the research, development, production and sale of fine chemicals, with a primary emphasis on amino acids and their derivatives.

Adlai Nortye’s product portfolio includes betaine compounds, a range of high-purity L-amino acids such as L-methionine, L-threonine and glycine, as well as various chemical intermediates. These offerings serve multiple end markets, including animal feed and nutrition, personal care and cosmetic formulations, pharmaceutical ingredients and industrial chemical processes.

The company operates multiple production facilities alongside an in-house research and development center dedicated to process innovation and quality control.